Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
By
Brendan Borrell
21 May 2026 | 6 min read
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
By
Calli McMurray
21 May 2026 | 6 min read
When autistic kids grow up
An autistic researcher’s paper called attention to a huge disparity in autism funding research between children and adults. It nearly derailed her life.
When autistic kids grow up
An autistic researcher’s paper called attention to a huge disparity in autism funding research between children and adults. It nearly derailed her life.
By
Brady Huggett
20 May 2026 | 2 min listen